Trial Profile
A phase I/IIa trial of intracranial injection of AU-101 in patients with recurrent glioblastoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jul 2016
Price :
$35
*
At a glance
- Drugs AU 101 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Aurora BioPharma
- 12 Jul 2016 Status changed from planning to completed, as per Aurora BioPharma pipeline.
- 16 Mar 2016 New trial record